Purification of recombinant human N-Acetyltransferase type 1 (NAT1) expressed in E. Coli and characterization of its potential role in folate metabolism

This publication has 39 references indexed in Scilit:

• Nomenclature for N-acetyltransferases
  Pharmacogenetics, 1995
• Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens
  Nature, 1994
• Expression of monomorphic and polymorphic N-acetyltransferases in human colon
  Biochemical Pharmacology, 1994
• Chromosomal localization of human genes for arylamine N-acetyltransferase
  Biochemical Journal, 1994
• Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases
  Carcinogenesis: Integrative Cancer Research, 1993
• Genotyping human polymorphic arylamine N-acetyltransferase: identification of new slow allotypic variants
  Pharmacogenetics, 1992
• Human ArylamineN-Acetyltransferase Genes: Isolation, Chromosomal Localization, and Functional Expression
  DNA and Cell Biology, 1990
• Evidence for two closely related isozymes of arylamine N‐acetyltransferase in human liver
  FEBS Letters, 1989
• New spectrophotometric and radiochemical assays for acetyl-CoA: Arylamine N-acetyltransferase applicable to a variety of arylamines
  Analytical Biochemistry, 1985
• ROLE OF N-ACETYLTRANSFERASE PHENOTYPES IN BLADDER CARCINOGENESIS: A PHARMACOGENETIC EPIDEMIOLOGICAL APPROACH TO BLADDER CANCER
  The Lancet, 1982